Company Overview

Elevance Health, Inc., formerly known as Anthem, Inc., is a leading health benefits company in the United States. Incorporated in 2001 and with roots dating back to 1944, the company has evolved to offer a wide spectrum of health plans and services across various segments of the population. It operates through four primary segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. Elevance Health is dedicated to improving the health of humanity by serving as a lifetime, trusted health partner.

Business Segments and Services

Elevance Health provides comprehensive health insurance solutions and services through its distinct business segments:

- Health Benefits Segment: This core segment encompasses a broad range of health insurance offerings, including plans for individual consumers, employer group risk-based and fee-based plans, BlueCard®, Medicare, Medicaid, and the Federal Employee Program (FEP). This segment forms the foundation of the company's operations, serving millions of members across the nation.

- CarelonRx: This segment focuses on pharmacy services, managing a full suite of offerings. These include home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy network development, rebate administration, prescription drug databases, and member services. It also provides infusion services and injectable therapies.

- Carelon Services: This segment delivers a wide array of healthcare-related services and capabilities designed to enhance health outcomes and operational efficiency. This includes specialty care enablement, utilization management support, behavioral health management, comprehensive care management services, palliative care services, virtual care solutions, payment integrity services, subrogation, clinical data exchange through its HealthOS platform, research and data analytics, reporting, IT support, and business process outsourcing.

- Brand Portfolio: The company delivers its diverse range of services under well-recognized brands, including Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon.

Financial Performance and Market Position

Elevance Health demonstrates a strong financial footing and a significant market presence in the US healthcare industry.

- Revenue and Growth: The company reported operating revenue of $175.2 billion in 2024, marking a $5.0 billion increase (3 percent) from the previous year. In 2023, revenue stood at $171.34 Billion USD. As of September 2025, Elevance Health's Trailing Twelve Months (TTM) revenue reached $189.25 Billion USD.

- Market Capitalization: As of September 22, 2025, Elevance Health's market capitalization was approximately $70.64 Billion USD. This valuation positions it as a significant entity in the global market.

- Profitability: For the full year 2024, net income was $5.98 billion, remaining flat compared to FY 2023. The profit margin was 3.4% (a slight decrease from 3.5% in FY 2023). Earnings Per Share (EPS) was $25.81.

- Cash Flow and Liquidity: Operating cash flow in 2024 was $5.8 billion, approximately 1.0 times GAAP net income. As of December 31, 2024, cash and investments at the parent company totaled approximately $2.4 billion.

Dividend Information

Elevance Health is committed to returning value to its shareholders through dividends and share repurchases.

- Quarterly Dividend: On January 22, 2025, a first-quarter 2025 dividend of $1.71 per share was declared, payable on March 25, 2025.

- Dividend Yield and Payout Ratio: In 2024, the company's dividend yield was 1.77%, with a payout ratio of 25.39%. This compares to 1.26% yield and a 23.47% payout ratio in the preceding year.

Stock Performance and Trading Information

- Historical Performance: Elevance Health (ELV) reached its all-time high of $567.26 USD on September 3, 2024. Its all-time low was recorded at $20.18 USD on October 30, 2001. The 52-week high stock price was $534.35, and the 52-week low was $273.71.

- Share Repurchase Program: In Q4 2024, the company repurchased 4.5 million shares of common stock for $1.8 billion. As of December 31, 2024, approximately $9.3 billion of Board-approved share repurchase authorization remained.

Company Statistics

- Employees: As of September 22, 2025, Elevance Health employed approximately 104,200 individuals.

- Company Profile: Elevance Health operates as a large-cap healthcare benefits provider with extensive operations across the United States, serving millions of members through its diverse portfolio of health plans and services.

Future Outlook and Strategic Direction

Elevance Health is strategically positioned to navigate the evolving healthcare landscape, focusing on its mission to improve the health of humanity.

- Strategic Focus: The company is prioritizing the expansion of its Carelon services platform, which integrates various healthcare capabilities to deliver comprehensive, whole-health solutions. This includes leveraging technology platforms like HealthOS for enhanced clinical data exchange.

- Growth Initiatives: Key initiatives involve expanding specialty care services, strengthening capabilities in behavioral health, and enhancing care management services to meet the increasing demand for integrated healthcare.

- Financial Strength: With strong cash flows, a robust balance sheet, and diversified revenue streams spanning health benefits, pharmacy services, and healthcare technology solutions, Elevance Health is well-equipped to maintain its position as a leading player in the industry and capitalize on future growth opportunities.